After layoffs at Recursion, the company’s CEO writes about taking inspiration from an unexpected source: “The Art of Racing ...

Insmed shares rocketed on results for a pulmonary arterial hypertension drug that exceeded Wall Street expectations.

Beyond the reported performance improvements, OpenAI announced a substantial price reduction for developers. O3-pro costs $20 ...

Learn how to implement backpropagation using automatic differentiation from the ground up in Python—no libraries, just pure ...

Recursion's AI-enabled drug discovery platform continues to evolve, but this is yet to translate into meaningful clinical ...